The biochemical response of the heart to hypertension and exercise
- PMID: 15501680
- DOI: 10.1016/j.tibs.2004.09.002
The biochemical response of the heart to hypertension and exercise
Abstract
Mechanical stress on the heart can lead to crucially different outcomes. Exercise is beneficial because it causes heart muscle cells to enlarge (hypertrophy). Chronic hypertension also causes hypertrophy, but in addition it causes an excessive increase in fibroblasts and extracellular matrix (fibrosis), death of cardiomyocytes and ultimately heart failure. Recent research shows that stimulation of physiological (beneficial) hypertrophy involves several signaling pathways, including those mediated by protein kinase B (also known as Akt) and the extracellular-signal-regulated kinases 1 and 2 (ERK1/2). Hypertension, beta-adrenergic stimulation and agonists such as angiotensin II (Ang II) activate not only ERK1/2 but also p38 and the Jun N-terminal kinase (JNK), leading to pathological heart remodeling. Despite this progress, the mechanisms that activate fibroblasts to cause fibrosis and those that differentiate between exercise and hypertension to produce physiological and pathological responses, respectively, remain to be established.
Similar articles
-
Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy.Circulation. 2008 Jan 29;117(4):545-52. doi: 10.1161/CIRCULATIONAHA.107.710434. Epub 2008 Jan 14. Circulation. 2008. PMID: 18195174
-
Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.Circ Res. 2010 Nov 12;107(10):1275-89. doi: 10.1161/CIRCRESAHA.110.229054. Epub 2010 Sep 16. Circ Res. 2010. PMID: 20847309
-
Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.Circ Res. 2006 Nov 24;99(11):1233-42. doi: 10.1161/01.RES.0000251074.19348.af. Epub 2006 Oct 26. Circ Res. 2006. PMID: 17068291
-
Cardiac fibroblasts: at the heart of myocardial remodeling.Pharmacol Ther. 2009 Aug;123(2):255-78. doi: 10.1016/j.pharmthera.2009.05.002. Epub 2009 May 19. Pharmacol Ther. 2009. PMID: 19460403 Review.
-
The role of cardiac fibroblasts in extracellular matrix-mediated signaling during normal and pathological cardiac development.J Biomech Eng. 2013 Jul 1;135(7):71001. doi: 10.1115/1.4024349. J Biomech Eng. 2013. PMID: 23720014 Review.
Cited by
-
Whole cell mechanics of contractile fibroblasts: relations between effective cellular and extracellular matrix moduli.Philos Trans A Math Phys Eng Sci. 2010 Feb 13;368(1912):635-54. doi: 10.1098/rsta.2009.0240. Philos Trans A Math Phys Eng Sci. 2010. PMID: 20047943 Free PMC article. Review.
-
Application of microRNA in cardiac and skeletal muscle disease gene therapy.Methods Mol Biol. 2011;709:197-210. doi: 10.1007/978-1-61737-982-6_12. Methods Mol Biol. 2011. PMID: 21194029 Free PMC article.
-
Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy.Circ Cardiovasc Genet. 2009 Apr;2(2):116-24. doi: 10.1161/CIRCGENETICS.108.806935. Epub 2009 Feb 18. Circ Cardiovasc Genet. 2009. PMID: 20031575 Free PMC article.
-
Thioredoxin and ventricular remodeling.J Mol Cell Cardiol. 2006 Nov;41(5):762-73. doi: 10.1016/j.yjmcc.2006.08.006. Epub 2006 Sep 26. J Mol Cell Cardiol. 2006. PMID: 17007870 Free PMC article. Review.
-
Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system.Pediatr Nephrol. 2009 Feb;24(2):367-77. doi: 10.1007/s00467-008-0978-8. Epub 2008 Sep 17. Pediatr Nephrol. 2009. PMID: 18797934
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous